Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26525998 | 1.00 | CFTR (0.31) | CFTRCYP2C9IDO1 | |
| SCHEMBL26526294 | 0.92 | CYP2C9 (0.31) | CYP2C9IDO1 | |
| SCHEMBL26526003 | 0.91 | CYP2C9 (0.32) | CYP2C9IDO1 | |
| SCHEMBL24984659 | 0.86 | — | — | |
| SCHEMBL31412378 | 0.85 | CFTR (0.33) | CFTRCYP2C9IDO1 | |
| SCHEMBL24988016 | 0.85 | CFTR (0.33) | CFTRCYP2C9IDO1 | |
| SCHEMBL18031468 | 0.83 | — | — | |
| SCHEMBL18031469 | 0.83 | — | — | |
| SCHEMBL18031368 | 0.83 | — | — | |
| SCHEMBL23904863 | 0.81 | CFTR (0.32) | CFTRCYP2C9IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230125803-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ENANTA PHARM INC (US) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230125803-A1 | ANTIVIRAL HETEROCYCLIC COMPOUNDS | ACE, HPRT1, ACE2 | CFTR 283/4885CYP2C9 429/4885IDO1 1041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.